The fund was granted for Check-Cap’s ingestible and disposable imaging capsule which has the capability to image the colon in 3D to help detect colorectal cancer.
Check-Cap said the capsule requires no bowel cleansing before ingestion and no hospital visit, allowing patients to go about their daily routines without having to alter their activities.
As part of the investment, Check-Cap and GE Healthcare have entered into a development and supply agreement where GE Healthcare-Israel will develop, design and produce miniature Cadmium Zinc Telluride (CZT) diagnostic imaging sensors inside each Check-Cap capsule to facilitate clinicians to obtain full 360-degree imaging as the capsule travels in the colon.
